Gene · 540
Papers3,770
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 3,770
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Personalized Technological Support for Informal Caregivers of Older People with Dementia: A Co-Design Approach Involving Potential End Users and Healthcare Professionals in Three Focus Groups in Italy. | Healthcare (Basel) | 2023 | 37830677 | PubTator, text mining | PubMed |
| Landscape and the immune patterns of cuproptosis in oral squamous cell carcinoma. | J Oral Pathol Med | 2023 | 37828627 | PubTator, text mining | PubMed |
| DLAT is a promising prognostic marker and therapeutic target for hepatocellular carcinoma: a comprehensive study based on public databases. | Sci Rep | 2023 | 37828099 | PubTator, text mining | PubMed |
| Multi-omics analysis of MRPL-13 as a tumor-promoting marker from pan-cancer to lung adenocarcinoma. | Aging (Albany NY) | 2023 | 37827692 | PubTator, text mining | PubMed |
| Identification and validation of potential diagnostic signature and immune cell infiltration for NAFLD based on cuproptosis-related genes by bioinformatics analysis and machine learning. | Front Immunol | 2023 | 37822923 | PubTator, text mining | PubMed |
| The role of novel programmed cell death in head and neck squamous cell carcinoma: from mechanisms to potential therapies. | Front Pharmacol | 2023 | 37818196 | PubTator, text mining | PubMed |
| The role of laboratory investigations in the classification of tremors. | Neurol Sci | 2023 | 37814130 | PubTator, text mining | PubMed |
| Prognostic value and immune landscapes of cuproptosis-related lncRNAs in esophageal squamous cell carcinoma. | Aging (Albany NY) | 2023 | 37812189 | PubTator, text mining | PubMed |
| Demographics and Outcomes Related to Wilson's Disease Patients: A Nationwide Inpatient Cohort Study. | Cureus | 2023 | 37809179 | PubTator, text mining | PubMed |
| YTHDF2 facilitates aggresome formation via UPF1 in an m6A-independent manner. | Nat Commun | 2023 | 37803021 | PubTator, text mining | PubMed |
| Erratum: Novel mutations in ATP7B in Chinese patients with Wilson's disease and identification of kidney disorder of thinning of the glomerular basement membrane. | Front Neurol | 2023 | 37799280 | PubTator, text mining | PubMed |
| Editorial: The roles of ion-induced cell death in cancer treatment: volume II. | Front Pharmacol | 2023 | 37786749 | PubTator, text mining | PubMed |
| Wilson's Disease Presents as Recurrent Hypokalemic Muscle Paralysis. | Indian J Nephrol | 2023 | 37781558 | PubTator, text mining | PubMed |
| Bioinformatics analysis of copper death gene in diabetic immune infiltration. | Medicine (Baltimore) | 2023 | 37773841 | PubTator, text mining | PubMed |
| Can Patients with Wilson's Disease Develop Copper Deficiency? | Mov Disord Clin Pract | 2023 | 37772303 | PubTator, text mining | PubMed |
| Copper homeostasis and cuproptosis in tumor pathogenesis and therapeutic strategies. | Front Pharmacol | 2023 | 37767404 | PubTator, text mining | PubMed |
| Recent Progress of Copper-Based Nanomaterials in Tumor-Targeted Photothermal Therapy/Photodynamic Therapy. | Pharmaceutics | 2023 | 37765262 | PubTator, text mining | PubMed |
| Novel Molecular Subtyping Scheme Based on In Silico Analysis of Cuproptosis Regulator Gene Patterns Optimizes Survival Prediction and Treatment of Hepatocellular Carcinoma. | J Clin Med | 2023 | 37762710 | PubTator, text mining | PubMed |
| Psychosis Caused by a Somatic Condition: How to Make the Diagnosis? A Systematic Literature Review. | Children (Basel) | 2023 | 37761400 | PubTator, text mining | PubMed |
| Abnormalities in Copper Status Associated with an Elevated Risk of Parkinson's Phenotype Development. | Antioxidants (Basel) | 2023 | 37759957 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/540/papers?page=24